IGHE and Alzheimer disease: However, good–partial responses were observed in patients with very high IgE levels, suggesting that the mechanism of omalizumab therapy in AD may be more complex than just neutralizing IgE.37, 38, 39 Response rates in different AD studies ranged between 40 and 100% of patients showing positive clinical outcomes.29